Skip to content
OpenCapital
Get started

Nuvation Bio NUVB Debt Securities, Unrealized Gain (Loss)

Debt Securities, Unrealized Gain (Loss) at other companies

Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$71K—
Zymeworks logo
ZymeworksZYME
$31K-78.3%
Customers Bancorp logo
Customers BancorpCUBI
$0+100%
NTS
Netskope, Inc. Class A Common StockNTSK
-$12.23M+63.4%
Blue Owl Technology Finance Corp. logo
Blue Owl Technology Finance Corp.OTF
-$490.7M-2,266%
Blue Owl Capital logo
Blue Owl CapitalOBDC
-$98.23M-151%

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesUnrealizedGainLoss.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's debt securities, unrealized gain (loss).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's debt securities, unrealized gain (loss)?
Nuvation Bio (NUVB) reported debt securities, unrealized gain (loss) of -$1.22M in Q1 2026.
How has Nuvation Bio's debt securities, unrealized gain (loss) changed year-over-year?
Nuvation Bio's debt securities, unrealized gain (loss) decreased by 147.9% year-over-year, from -$493K to -$1.22M.
What is the long-term trend for Nuvation Bio's debt securities, unrealized gain (loss)?
Over 3 years (2021 to 2025), Nuvation Bio's debt securities, unrealized gain (loss) has grown at a -35.3% compound annual growth rate (CAGR), from -$2.74M to $741K.
What does debt securities, unrealized gain (loss) mean?
This metric measures the change in the market value of debt securities held in the company's investment portfolio that have not yet been sold. It reflects the impact of interest rate changes and credit spread movements on the company's liquid assets. Investors monitor this to assess the performance of the company's treasury management and the potential impact on future liquidity.